Can anyone add to this (short) list?

Hey Greg,

I recently bought the book From Alchemy to IPO by Cynthia Robbins-Roth (http://www.amazon.com/exec/obidos/ASIN/0738202533/qid%3D970004623/102-3110790-5305719). I think you'll be doing a seminar with her in the near future. :-) In the chapter on tissue engineering, she lists all the companies, both public and private. Here is the list:

Acorda (Private) -- Growth factors, scar blockers, matrix for spinal cord

Advanced Tissue Sciences (ATIS) -- Matrix and growth factors for skin, cartilage, connective tissues. Market Cap (millions): $478

Cell Based Delivery (Private) -- Muscle cells engineered to deliver theraputic genes

CellMart (Private) -- Matrix and cell proliferation technology for pancreas

Circe Biomedical (Private) -- Cell replacement for liver

Cryolife (CRY) -- Heart valves (gotta love the ticker symbol!) Market Cap (millions): $406

Curis (CRIS) -- web site was a little vague. I didn't have time right now to dig deeper. Market Cap (millions): $714

Desmos (Private) -- Cell adhesion and proliferation for skin, connective tissues, pancreas

Diacrin (DCRN) -- Animal organs to replace pancreas and neurons, cell therapy. Market Cap (millions): $134

Encelle (Private) -- Animal organs to replace pancreas

Genzyme General Corp. (GENZ) -- Brain cell implants. Market Cap (millions): $5,735

Genzyme Tissue Repair (GZTR) -- Matrix and cell technology for cartilage, skin. Market Cap (millions): $142

Integra LifeSciences (IART) -- Matrix and cell technology for skin, tissue/bone/cartilage regeneration. Market Cap (millions): $192

Lifecell (LIFC) -- Engineering of animal tissues for heart, skin, connective tissue. Market Cap (millions): $64

Molecular Geodesics (Private) -- Biomimetrics for tissue engineering, bioimplants

MorphoGen Pharmaceuticals (Private) -- Stem cells, matrix, and growth factors for muscle

NeuralStem Biopharmaceuticals (Private) -- Brain stem cells (Note to Greg: these guys are located in College Park, MD, so they are within driving distance in case you want to go check them out--assuming you're still living in Arlington)

Organogenesis (ORG) -- Matrix and cell technology for skin, liver, connective tissue, blood vessels. Market Cap (millions): $482

Orquest (Private) -- Bone

Ortec International (ORTC) -- skin engineering. Market Cap (millions): $80

Orthavita (Private) -- Spine tissue engineering, bone substitutes

Osiris Therapeutics (Private) -- Stem cells and growth factors for mesencymal cells (Note: these guys are in Baltimore, MD)

Osteotech (OSTE) -- Bone graft matrix and factors. Market Cap (millions): $186

Progenitor Cell Therapy LLC (Private) -- Blood stem cells

Proneuron Biotechnologies (Private) -- Spinal cord repair

ReGen Biologics (Private) -- Matrix and cell technology for cartilage

Reprogenesis (Private) -- Matrix and cell technology for connective tissue to rebuild organs

Spinal Concepts Inc./Selective Genetics Inc. (Private) -- Growth factors for bone delivered in a spinal fusion device

Stem Cells (STEM) -- Cell therapy in brain tissue. Market Cap (millions): $132

Titan Pharmaceuticals (TTP) -- Matrix and cell technology for brain. Market Cap (millions): $1,221

There you have it! By the way, I highly recommend the aforementioned book. I'm about a third of the way through it and I'm learning a lot. On with the research!

-David